SMAD4 and metabolic dysfunction-associated steatohepatitis: Additionally, they reported that deletion of SMAD4 in NASH mice models showed decreased hepatic steatosis, inflammation, liver cell apoptosis and nonalcoholic fatty liver activity score compared with wild-type mice.